217 related articles for article (PubMed ID: 29791916)
21. Diclofenac sodium 3% gel for the management of actinic keratosis: 10+ years of cumulative evidence of efficacy and safety.
Martin GM; Stockfleth E
J Drugs Dermatol; 2012 May; 11(5):600-8. PubMed ID: 22527428
[TBL] [Abstract][Full Text] [Related]
22. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.
Neri L; Peris K; Longo C; Calvieri S; Frascione P; Parodi A; Eibenschuz L; Bottoni U; Pellacani G;
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):93-107. PubMed ID: 29920789
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis.
Kose O; Koc E; Erbil AH; Caliskan E; Kurumlu Z
J Dermatolog Treat; 2008; 19(3):159-63. PubMed ID: 18569272
[TBL] [Abstract][Full Text] [Related]
24. Topical diclofenac 3% gel plus cryotherapy for treatment of multiple and recurrent actinic keratoses.
Mastrolonardo M
Clin Exp Dermatol; 2009 Jan; 34(1):33-5. PubMed ID: 18616726
[TBL] [Abstract][Full Text] [Related]
25. Comparative study of actinic keratosis treatment with 3% diclofenac sodium and 5% 5-fluorouracil.
Segatto MM; Dornelles SI; Silveira VB; Frantz Gde O
An Bras Dermatol; 2013; 88(5):732-8. PubMed ID: 24173178
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment with ablative fractional carbon dioxide laser improves treatment efficacy in a synergistic PDT protocol for actinic keratoses on the head.
Falkenberg C; Schmitz L; Dicke K; Dervenis V; Szeimies RM; Dirschka T
Photodiagnosis Photodyn Ther; 2021 Jun; 34():102249. PubMed ID: 33711530
[TBL] [Abstract][Full Text] [Related]
27. A single-arm, open-label efficacy and tolerability study of diclofenac sodium 3% gel for the treatment of actinic keratosis of the upper and lower lip.
Nelson CG; Spencer J; Nelson CG
J Drugs Dermatol; 2007 Jul; 6(7):712-7. PubMed ID: 17763595
[TBL] [Abstract][Full Text] [Related]
28. Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratoses.
Jarvis B; Figgitt DP
Am J Clin Dermatol; 2003; 4(3):203-13. PubMed ID: 12627996
[TBL] [Abstract][Full Text] [Related]
29. Modes of action of diclofenac 3%/hyaluronic acid 2.5% in the treatment of actinic keratosis.
Maltusch A; Röwert-Huber J; Matthies C; Lange-Asschenfeldt S; Stockfleth E
J Dtsch Dermatol Ges; 2011 Dec; 9(12):1011-7. PubMed ID: 21585654
[TBL] [Abstract][Full Text] [Related]
30. Treatment of actinic keratosis through inhibition of cyclooxygenase-2: Potential mechanism of action of diclofenac sodium 3% in hyaluronic acid 2.5.
Thomas GJ; Herranz P; Cruz SB; Parodi A
Dermatol Ther; 2019 May; 32(3):e12800. PubMed ID: 30523664
[TBL] [Abstract][Full Text] [Related]
31. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
Bettencourt MS
J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Actinic Keratosis and Severity Index with Physician Global Assessment and Total Lesion Count and the Ability to Predict Skin Cancer.
Acar A; Karaarslan I
Dermatol Pract Concept; 2022 Feb; 12(1):e2022031. PubMed ID: 35223175
[TBL] [Abstract][Full Text] [Related]
33. Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.
Berlin JM; Rigel DS
J Drugs Dermatol; 2008 Jul; 7(7):669-73. PubMed ID: 18664159
[TBL] [Abstract][Full Text] [Related]
34. Monitoring treatment of field cancerisation with 3% diclofenac sodium 2.5% hyaluronic acid by reflectance confocal microscopy: a histologic correlation.
Malvehy J; Roldán-Marín R; Iglesias-García P; Díaz A; Puig S
Acta Derm Venereol; 2015 Jan; 95(1):45-50. PubMed ID: 24696069
[TBL] [Abstract][Full Text] [Related]
35. Sequential methyl-aminolevulinate daylight photodynamic therapy and diclofenac plus hyaluronic acid gel treatment for multiple actinic keratosis evaluation.
Cantisani C; Paolino G; Scarnò M; Didona D; Tallarico M; Moliterni E; Losco L; Cantoresi F; Mercuri SR; Bottoniτ U; Calvieri S
Dermatol Ther; 2018 Nov; 31(6):e12710. PubMed ID: 30253027
[No Abstract] [Full Text] [Related]
36. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses.
Wolf JE; Taylor JR; Tschen E; Kang S
Int J Dermatol; 2001 Nov; 40(11):709-13. PubMed ID: 11737438
[TBL] [Abstract][Full Text] [Related]
37. Variables in Cryosurgery Technique Associated With Clearance of Actinic Keratosis.
Berman B; Shabbir AQ; MacNeil T; Knudsen KM
Dermatol Surg; 2017 Mar; 43(3):424-430. PubMed ID: 28002105
[TBL] [Abstract][Full Text] [Related]
38. The safety of diclofenac for the management and treatment of actinic keratoses.
Iraji F; Siadat AH; Asilian A; Enshaieh S; Shahmoradi Z
Expert Opin Drug Saf; 2008 Mar; 7(2):167-72. PubMed ID: 18324879
[TBL] [Abstract][Full Text] [Related]
39. Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study.
Kirchberger MC; Gfesser M; Erdmann M; Schliep S; Berking C; Heppt MV
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510952
[TBL] [Abstract][Full Text] [Related]
40. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
Berman B; Nestor MS; Newburger J; Park H; Swenson N
J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
